Dow Down 0.25% Nasdaq Down 0.14%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.25 0.14(3.41%) Sep 29, 4:00PM EDT
Prev Close:4.11
Open:4.10
Bid:4.13 x 3400
Ask:4.55 x 600
1y Target Est:7.00
Beta:-2.28
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:4.06 - 4.25
52wk Range:3.82 - 7.97
Volume:2,848,286
Avg Vol (3m):5,022,930
Market Cap:934.30M
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 3.41%934.30M
GSK111.19B
OREX553.85M
RHHBY250.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback